HIV ‐1 viral protein effect on cerebral microvasculature: An in vitro blood–brain barrier model
Physiological Reports · 2025
DOI: 10.14814/phy2.70593 ↗At a glance
Journal article in Physiological Reports, 2025. Written by Sinelisiwe Matubatuba and 5 co-authors. Institution: Division of Cell Biology, Department of Human Biology, Anatomy Building, Medical Campus University of Cape Town, Cape Town, South Africa. Major MEDLINE topics: Blood-Brain Barrier, HIV-1, Microvessels. Cited 3 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Research Foundation (NRF).
Abstract (original language)
The central nervous system (CNS) serves as a sanctuary for the Human Immunodeficiency Virus (HIV), which is facilitated by HIV's ability to breach the blood–brain barrier (BBB). BBB dysfunction occurs in the earliest stages of an HIV‐1 infection. The immune‐privileged CNS reduces harmful inflammatory responses, detrimental to the neuronal environment. BBB disruption, however, contributes to comorbidities in HIV, like cerebrovascular disease and neurocognitive problems. A 2‐dimensional in vitro BBB model was employed to assess the effect of HL2/3 cell paracrine factors on select physiological parameters: cell proliferation, viability, toxicity, suppression, and morphology. BBB integrity was assessed using transendothelial electrical resistance measurements. The study utilized immortalized mouse brain endothelial cell monocultures and co‐cultures with the HL2/3 cell line, emulating an in vivo HIV‐1 effect on the BBB. A concentration‐dependent decline in cellular proliferation rates and viability was observed upon exposure to HL2/3 paracrine factors. Moreover, an elevation in cellular suppression, cell death, and cell toxicity was observed. Permeability studies confirmed decreased impermeability after exposure to HIV‐1 viral proteins in select in vitro BBB model systems. The impact of HIV viral proteins on brain capillary endothelium is critical to elucidate pathogen‐induced cerebrovascular disease progression and vascular cognitive impairment in patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cell Biology, Department of Human Biology, Anatomy Building, Medical Campus University of Cape Town, Cape Town, South Africa.
- Neurobiology Research Group, Department of Medical Biosciences, New Life Sciences Building, University of the Western Cape, Cape Town, South Africa.
- Experimental Medicine Group, Department Medicine, Stellenbosch University, Cape Town, South Africa.
- School of Health Professions, University of Missouri, Columbia, Missouri, USA.
- Department of Physiological Sciences, Mike De Vries Building, Stellenbosch University, Stellenbosch, South Africa.
ORCID profiles: Sinelisiwe Matubatuba, Carine Smith, David Fisher, Shireen Mentor
Funding
- National Research Foundation (NRF)
Cite
APA
Matubatuba, S., Willemse, C., Makhathini, K. B., Smith, C., Fisher, D., & Mentor, S. (2025). HIV ‐1 viral protein effect on cerebral microvasculature: An in vitro blood–brain barrier model. Physiological Reports. https://doi.org/10.14814/phy2.70593
Vancouver
Matubatuba S, Willemse C, Makhathini KB, Smith C, Fisher D, Mentor S. HIV ‐1 viral protein effect on cerebral microvasculature: An in vitro blood–brain barrier model. Physiological Reports. 2025. doi:10.14814/phy2.70593
BibTeX
@article{Matubatuba2025,
author = {Matubatuba, Sinelisiwe and Willemse, Chontrelle and Makhathini, Khayelihle Brian and Smith, Carine and Fisher, David and Mentor, Shireen},
title = {HIV ‐1 viral protein effect on cerebral microvasculature: An in vitro blood–brain barrier model},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70593}
}
EUVIMED